Harrow (HROW) EBITDA Margin (2013 - 2026)
Harrow (HROW) reported EBITDA Margin of -7.10% for Q2 2026, down 32.41 percentage points from 25.31% a year earlier but up 30.21 percentage points from the prior quarter.
Harrow (HROW) EBITDA Margin (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Harrow's EBITDA Margin came in at 6.65%, down 7.17 percentage points year-over-year; for FY2025, it was 18.15%, up 6.90 percentage points from FY2024.
- EBITDA Margin has increased for four consecutive years, with a five-year change of +13.17 percentage points (FY2020 to FY2025).
- By year, EBITDA Margin came in at 11.25% in FY2024 (+2.00 pp), 9.25% in FY2023 (+3.64 pp), 5.61% in FY2022 (+0.80 pp) and 4.82% in FY2021 (-0.16 pp).
- Five-year quarterly EBITDA Margin spans a low of -37.32% in Q1 2026 and a high of 27.17% in Q3 2025.
- Year over year, EBITDA Margin has now declined in each of the last three quarters, with an average year-over-year change of -0.07 percentage points over the last eight quarters.
- The high point for year-over-year EBITDA Margin in five years was Q4 2024 (a gain of 31.58 percentage points); the low point was Q2 2026 (a drop of 32.41 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -37.32% (Q1 2026), 22.86% (Q4 2025) and 27.17% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,154.54 Bn | 1,123.13 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 623.94 Bn | 542.46 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 511.93 Bn | 485.04 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 365.40 Bn | 319.78 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 297.27 Bn | 261.26 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.30 Bn | 234.99 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 234.77 Bn | 190.17 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 192.76 Bn | 166.96 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 171.68 Bn | 118.33 Bn | 10.94 Bn | 39.16% |
| 10 | Harrow | 1.06 Bn | 738.55 Mn | 50.36 Mn | -6.54% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6.54% |
| Mar 31, 2026 | -36.30% |
| Dec 31, 2025 | 23.27% |
| Sep 30, 2025 | 28.74% |
| Jun 30, 2025 | 27.33% |
| Mar 31, 2025 | -11.01% |
| Dec 31, 2024 | 27.92% |
| Sep 30, 2024 | 11.08% |
| Jun 30, 2024 | 11.25% |
| Mar 31, 2024 | -8.58% |
| Dec 31, 2023 | -1.27% |
| Sep 30, 2023 | 16.57% |
| Jun 30, 2023 | 19.29% |
| Mar 31, 2023 | 17.12% |
| Dec 31, 2022 | -4.01% |
| Sep 30, 2022 | 3.28% |
| Jun 30, 2022 | 11.61% |
| Mar 31, 2022 | 14.09% |
| Dec 31, 2021 | -5.33% |
| Sep 30, 2021 | -16.48% |
Harrow EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=HROW&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "HROW", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=HROW&period=max&api_key=YOUR_API_KEY");
const data = await res.json();